VRPX Insider Trading Activity and SEC Form 4 Filings
VRPX insider trading summary
No open-market insider purchases or sales of Virpax Pharmaceuticals, Inc. (VRPX) have been reported on SEC Form 4 in the past 12 months.
Latest VRPX insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| May 24, 2022 | Jerrold Sendrow | Director | Buy | $6K (4,500 @ $1.29) |
| May 18, 2022 | Eric Floyd | Director | Buy | $6K (4,479 @ $1.36) |
| May 18, 2022 | Anthony P. Mack | Chief Executive Officer | Buy | $102K (75,750 @ $1.34) |
| Nov 22, 2021 | Jerrold Sendrow | Director | Buy | $15K (3,900 @ $3.92) |
| Nov 18, 2021 | Anthony P. Mack | Chief Executive Officer | Buy | $100K (25,125 @ $3.99) |
| Feb 17, 2021 | Gary S Jacob | Director | Buy | $24K (3,500 @ $6.79) |
| Feb 17, 2021 | Thani Jambulingam | Director | Buy | $716 (100 @ $7.16) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.